UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000041972
Receipt No. R000047736
Scientific Title Clinical trial on the effects of dietary intake of sulforaphane-rich broccoli sprouts on severity of ulcerative colitis.
Date of disclosure of the study information 2020/10/01
Last modified on 2020/10/01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinical trial on the effects of dietary intake of sulforaphane-rich broccoli sprouts on severity of ulcerative colitis.
Acronym BS-UC-2020
Scientific Title Clinical trial on the effects of dietary intake of sulforaphane-rich broccoli sprouts on severity of ulcerative colitis.
Scientific Title:Acronym BS-UC-2020
Region
Japan

Condition
Condition ulcerative colitis
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine if dietary intake of sulforaphane-rich broccoli sprouts improve ulcerative colitis.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Fecal calprotectin level (before and after 8 weeks treatment)
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 Broccoli Sprouts (20 g/day, 8 weeks)
Interventions/Control_2 Alfalfa Sprouts (20 g/day, 8 weeks)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. Age higher than 20 years.
2. Mild UC (Rachmilewits index less than 5)
3. Presence of maintenance therapy with mesalazine
4. Appropriate informed consent
5. Fecal Protectin level higher than upper limit of normal value
Key exclusion criteria 1. Regular use of lactobacillus, steroids, immuno-modulators, biological drugs, caclineurin inhibitors, JAK kinase inhibitors.
2. Fecal Protectin level less than upper limit of normal value
3. Hospitalized Patients
4. Start of ASA treatment, or iIncrease in 5-ASA within 4 weeks
5. G-CAP or L-CAP treatment within 3 months
6. Treatment with herbal medicine including quingdao
7. Any other reasons judged by the principle investigator
Target sample size 50

Research contact person
Name of lead principal investigator
1st name Akinori
Middle name
Last name Yanaka
Organization University of Tsukuba Hospital
Division name Hitachi Medical Education and Reserach Center
Zip code 317-0077
Address 2-1-1 Jounann-cho, Hitachi-shi, Ibaraki-ken
TEL 0294-23-1111
Email ynk-aki@md.tsukuba.ac.jp

Public contact
Name of contact person
1st name Akinori
Middle name
Last name Yanaka
Organization University of Tsukuba
Division name Hitachi Medical Education and Research Center
Zip code 317-0077
Address 2-1-1, Jounan-cho, Hitachi-shi, Ibaraki-ken
TEL 0294-23-1111
Homepage URL
Email ynk-aki@md.tsukuba.ac.jp

Sponsor
Institute University of Tsukuba
Institute
Department

Funding Source
Organization Japanese Society for the Promotion of Science
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Hitachi General Hospital
Address 2-1-1, Jounan-cho, Hitachi-shi, Ibaraki-ken
Tel 0294-23-1111
Email masahiro.miura.cz@hitachi.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 10 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2020 Year 08 Month 03 Day
Date of IRB
2020 Year 08 Month 31 Day
Anticipated trial start date
2020 Year 10 Month 01 Day
Last follow-up date
2024 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 10 Month 01 Day
Last modified on
2020 Year 10 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047736

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.